Brain Sciences (Dec 2023)

Activity of Protein Kinase A in the Frontal Cortex in Schizophrenia

  • Smita Sahay,
  • Nicholas Daniel Henkel,
  • Christina Flora-Anabelle Vargas,
  • Robert Erne McCullumsmith,
  • Sinead Marie O’Donovan

DOI
https://doi.org/10.3390/brainsci14010013
Journal volume & issue
Vol. 14, no. 1
p. 13

Abstract

Read online

Schizophrenia is a serious cognitive disorder characterized by disruptions in neurotransmission, a process requiring the coordination of multiple kinase-mediated signaling events. Evidence suggests that the observed deficits in schizophrenia may be due to imbalances in kinase activity that propagate through an intracellular signaling network. Specifically, 3′-5′-cyclic adenosine monophosphate (cAMP)-associated signaling pathways are coupled to the activation of neurotransmitter receptors and modulate cellular functions through the activation of protein kinase A (PKA), an enzyme whose function is altered in the frontal cortex in schizophrenia. In this study, we measured the activity of PKA in human postmortem anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC) tissue from schizophrenia and age- and sex-matched control subjects. No significant differences in PKA activity were observed in male and female individuals in either brain region; however, correlation analyses indicated that PKA activity in the ACC may be influenced by tissue pH in all subjects and by age and tissue pH in females. Our data provide novel insights into the function of PKA in the ACC and DLPFC in schizophrenia.

Keywords